Drugs / H021 Enteric-coated Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07677514 | Jul → Oct 2026 expected | Crohn disease | Jiangsu Carephar Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H021 Enteric-coated Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07677514 ↗ |